Share Name Share Symbol Market Type Share ISIN Share Description
Freyherr International Group Plc NEX:FRYR NEX Ordinary Share GB00BJK3K011
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 97.50 90.00 110.00 97.50 97.50 97.50 0.00 07:50:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - -

Freyherr International Group PLC Admission to NEX Exchange - First Day of Dealing

13/08/2019 7:30am

UK Regulatory (RNS & others)


Freyherr (NEX:FRYR)
Historical Stock Chart

6 Months : From Jun 2019 to Dec 2019

Click Here for more Freyherr Charts.

TIDMFRYR

RNS Number : 7906I

Freyherr International Group PLC

13 August 2019

Freyherr International Group plc

First Day of Dealing Announcement

The Directors of Freyherr International Group plc ('Freyherr International' or 'the Company'), the medicinal cannabis group based in Slovenia, are pleased to announce that its application for the ordinary shares of GBP0.01 each in the Company to be admitted to trading on the NEX Exchange Growth Market has been approved and that trading in the shares will commence at 8 a.m. on Tuesday 13 August 2019.

So far 2019 has been a year of consolidation and re-structuring as the Freyherr International Group became fully formed with Patron becoming a wholly owned subsidiary of Freyherr d.o.o. and with Freyherr d.o.o. completing the purchase of its 30% minority interest in Freyherr Pharma d.o.o. for shares at the Admission price.

In addition to the consideration shares the Company concluded a small private placing that has raised some GBP190,000 in cash. In total the Company has allotted 511,353 Ordinary Shares at 170p per share. The Directors believe that this will help the Company to accelerate its trading performance, while admission to the NEX Growth Market will provide further benefits:

-- its profile will benefit from the status of being a company whose shares are traded publicly;

-- its ability to attract, motivate and retain key staff through the future grant of share options will be enhanced;

   --     potential partners will be more ready to partner with a quoted company; 

-- open reporting, market information and the transparency required of a publicly traded company should enhance the Company's status with regulatory authorities.

This year Freyherr has also commenced cultivation of hemp on 20 hectares of agricultural land rented on long-term rental contracts, located in the Mediterranean climate region in Sečovlje, Slovenia. Freyherr Slovenia provides the expertise, the selection of seed and production support through all phases of production

COMPANY PROFILE

Freyherr International Group plc is the UK parent company of a group engaged in the production and sale of medicinal cannabis, cannabis cultivation and the production of cannabis dosing and dispensing packaging. Operations are centred in Slovenia and the Group principally operates within the EU.

The Group currently consists of 3 operating companies:

Freyherr d.o.o. has expertise in the cultivation and harvesting of cannabis as well as the formulation, marketing and distribution of cannabis and cannabis derived concentrates and extracts. It is currently growing cannabis in Slovenia and has invested in various cannabis production facilities in other jurisdictions.

Freyherr Pharma d.o.o. is the analytics and pharmaceutical arm of the Group and holds an EU GMP certificate. It operates from its own certified building and manufactures CBD products for the Group and produces white label CBD products supplying them to various EU countries;

Patron d.o.o. is the dosing and dispensing arm which has been trading since 2015 it markets products suitable for dispensing concentrates and extracts of all sorts of nutritional and pharmaceutical products. The company also offers Cannabinoid analysis to identify the THC, CBD, or CBN levels in a given extract, concentrate or plant;

SUBSTANTIAL SHAREHOLDINGS:

Directors Holdings:

 
 Name                             Number of Ordinary Shares   Current % of Ordinary 
                                        at the date of this                  Shares 
                                               Announcement 
 Luka Freyer                                      7,323,232                 28.42 % 
 Toma Frelih*(1)                                  7,133,838                 27.69 % 
 Eva Tavčar Benković                    3,535,353                 13.72 % 
 Boris Er en *(2)                                 1,010,100                  3.72 % 
 Tony Burke                                             nil                  0.00 % 
 

(*1) These shares are held by Profiling d.o.o., incorporated in Slovenia, of which Mr Frelih and his wife are the sole directors and shareholders.

(*2) These shares are held by Gedala Limited, incorporated in Cyprus, and its wholly owned subsidiary Avemontis d.o.o. incorporated in Slovenia. Mr Er en is the ultimate beneficial owner of Gedala Limited.

Other substantial Shareholders (3% or above)

 
 Name                           Number of Ordinary Shares   Current % of Ordinary 
                                      at the date of this                  Shares 
                                             Announcement 
 Beautiful Things Foundation                    2,777,777                 10.78 % 
 Marko Rogl                                     1,111,111                  4.31 % 
 

City & Merchant is currently entitled to 257,639 warrants to subscribe for Ordinary Shares at various prices and exercise dates.

FURTHER BACKGROUND

 
 Incorporation Details:        Freyherr International Group plc registered 
                                in England and Wales with company number 
                                11160911; 
 Registered Office             No. 1 London Bridge, London SE1 9BG; 
 Principal place of business   Kersnikova ulica 10, 1000 Ljubljana, 
                                Slovenia; 
 Ticker                        FRYR; 
 ISIN                          GB00BJK3K011; 
 Sector Classification         Pharmaceuticals and Biotechnology; 
 Website                       www.freyherr.com 
 Shares in public hands        15.38%; 
 

A copy of the Admission Document is available on the Company's website and from the Corporate Advisor - City & Merchant - info@cityandmerchant.com or 0207 101 7676.

The directors of the issuer accept responsibility for the contents of this announcement

For further information please contact:

FREYHERR INTERNATIONAL GROUP PLC

Toma Frelih 00 386 (41) 444 845

Freyherr International Group plc

No.1 London Bridge

London SE1 9BG

CITY & MERCHANT LIMITED

Corporate Advisor

David Papworth 0207 101 7676

info@cityandmerchant.co.uk

Level 17 Dashwood House

69 Old Broad Street

London

EC2M 1QS

HELFORD CAPITAL PARTNERS LLP

Investor Relations

Tony Burke 020 7839 5081

97 Jermyn Street

London

SW1Y 6JE

Note to Editors:

Freyherr International Group plc is the UK parent company of a group engaged in the production and sale of medicinal cannabis, cannabis cultivation and the production of cannabis dosing and dispensing packaging. Operations are centred in Slovenia and the Group principally operates within the EU.

The Group currently consists of 3 operating companies:

Freyherr d.o.o. has expertise in the cultivation and harvesting of cannabis as well as the formulation, marketing and distribution of cannabis and cannabis derived concentrates and extracts. It is currently growing cannabis in Slovenia and has invested in various cannabis production facilities in other jurisdictions.

Freyherr Pharma d.o.o. is the analytics and pharmaceutical arm of the Group and holds an EU GMP certificate. It operates from its own certified building and manufactures CBD products for the Group and produces white label CBD products supplying them to various EU countries;

Patron d.o.o. is the dosing and dispensing arm which has been trading since 2015 it markets products suitable for dispensing concentrates and extracts of all sorts of nutritional and pharmaceutical products. The company also offers Cannabinoid analysis to identify the h THC, CBD, or CBN levels in a given extract, concentrate or plant;

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NEXEAXPAFLNNEFF

(END) Dow Jones Newswires

August 13, 2019 02:30 ET (06:30 GMT)

1 Year Freyherr Chart

1 Year Freyherr Chart

1 Month Freyherr Chart

1 Month Freyherr Chart
Your Recent History
NEX
FRYR
Freyherr
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191205 19:15:31